Guizhou Sanli Pharmaceutical Co., Ltd. Class ASSE: 603439

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Expected Decrease in Semi-annual Performance for 2026

· Issued by Guizhou Sanli Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Expected Decrease in Semi-annual Performance for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Guizhou Sanli Pharmaceutical Co., Ltd. Class A

All Guizhou Sanli Pharmaceutical Co., Ltd. Class A news releases